These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 30217993)

  • 1. Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration.
    Rakic R; Bourdon B; Demoor M; Maddens S; Saulnier N; Galéra P
    Sci Rep; 2018 Sep; 8(1):13799. PubMed ID: 30217993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.
    Contentin R; Demoor M; Concari M; Desancé M; Audigié F; Branly T; Galéra P
    Stem Cell Rev Rep; 2020 Feb; 16(1):126-143. PubMed ID: 31745710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia Is a Critical Parameter for Chondrogenic Differentiation of Human Umbilical Cord Blood Mesenchymal Stem Cells in Type I/III Collagen Sponges.
    Gómez-Leduc T; Desancé M; Hervieu M; Legendre F; Ollitrault D; de Vienne C; Herlicoviez M; Galéra P; Demoor M
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.
    Branly T; Bertoni L; Contentin R; Rakic R; Gomez-Leduc T; Desancé M; Hervieu M; Legendre F; Jacquet S; Audigié F; Denoix JM; Demoor M; Galéra P
    Stem Cell Rev Rep; 2017 Oct; 13(5):611-630. PubMed ID: 28597211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.
    Desancé M; Contentin R; Bertoni L; Gomez-Leduc T; Branly T; Jacquet S; Betsch JM; Batho A; Legendre F; Audigié F; Galéra P; Demoor M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering.
    Gómez-Leduc T; Hervieu M; Legendre F; Bouyoucef M; Gruchy N; Poulain L; de Vienne C; Herlicoviez M; Demoor M; Galéra P
    Sci Rep; 2016 Sep; 6():32786. PubMed ID: 27604951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAs.
    Legendre F; Ollitrault D; Gomez-Leduc T; Bouyoucef M; Hervieu M; Gruchy N; Mallein-Gerin F; Leclercq S; Demoor M; Galéra P
    Sci Rep; 2017 Jun; 7(1):3406. PubMed ID: 28611369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Effects of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Combined with Cartilage Acellular Matrix Mediated Via Bone Morphogenic Protein 6 in a Rabbit Model of Articular Cruciate Ligament Transection.
    Jeon HJ; Yoon KA; An ES; Kang TW; Sim YB; Ahn J; Choi EK; Lee S; Seo KW; Kim YB; Kang KS
    Stem Cell Rev Rep; 2020 Jun; 16(3):596-611. PubMed ID: 32112264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.
    De Schauwer C; Goossens K; Piepers S; Hoogewijs MK; Govaere JL; Smits K; Meyer E; Van Soom A; Van de Walle GR
    Stem Cell Res Ther; 2014 Jan; 5(1):6. PubMed ID: 24418262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.
    Branly T; Contentin R; Desancé M; Jacquel T; Bertoni L; Jacquet S; Mallein-Gerin F; Denoix JM; Audigié F; Demoor M; Galéra P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage-Specific Gene Expression and Extracellular Matrix Deposition in the Course of Mesenchymal Stromal Cell Chondrogenic Differentiation in 3D Spheroid Culture.
    Vakhrushev IV; Basok YB; Baskaev KK; Novikova VD; Leonov GE; Grigoriev AM; Belova AD; Kirsanova LA; Lupatov AY; Burunova VV; Kovalev AV; Makarevich PI; Sevastianov VI; Yarygin KN
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cartilage oligomeric matrix protein on bone morphogenetic protein-2-induced differentiation of mesenchymal stem cells.
    Guo P; Shi ZL; Liu A; Lin T; Bi F; Shi M; Yan SG
    Orthop Surg; 2014 Nov; 6(4):280-7. PubMed ID: 25430711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal cells condensation-inducible mesh scaffolds for cartilage tissue engineering.
    Kim IG; Ko J; Lee HR; Do SH; Park K
    Biomaterials; 2016 Apr; 85():18-29. PubMed ID: 26854388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of soluble growth factors in the chondrogenic response of human umbilical cord matrix stem cells in a porous three dimensional scaffold.
    Nirmal RS; Nair PD
    Eur Cell Mater; 2013 Nov; 26():234-51. PubMed ID: 24213879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells.
    Ronzière MC; Perrier E; Mallein-Gerin F; Freyria AM
    Biomed Mater Eng; 2010; 20(3):145-58. PubMed ID: 20930322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SOX9 enhanced chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation].
    Xu Y; Chen L; Shi Y; Gu Y; Zou J; Huang C; Tang TS
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2050-4. PubMed ID: 23253807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage Repair Using Composites of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronic Acid Hydrogel in a Minipig Model.
    Ha CW; Park YB; Chung JY; Park YG
    Stem Cells Transl Med; 2015 Sep; 4(9):1044-51. PubMed ID: 26240434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells.
    Murphy MK; Huey DJ; Hu JC; Athanasiou KA
    Stem Cells; 2015 Mar; 33(3):762-73. PubMed ID: 25377511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of mesenchymal stromal cells from different tissue sources in respect to articular cartilage tissue engineering.
    Danišovič Ľ; Boháč M; Zamborský R; Oravcová L; Provazníková Z; Csöbönyeiová M; Varga I
    Gen Physiol Biophys; 2016 Apr; 35(2):207-14. PubMed ID: 26891275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.